CDMO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CDMO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Avid Bioservices's Cost of Goods Sold for the three months ended in Jan. 2024 was $31.4 Mil. Avid Bioservices's Average Total Inventories for the quarter that ended in Jan. 2024 was $36.6 Mil. Avid Bioservices's Inventory Turnover for the quarter that ended in Jan. 2024 was 0.86.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Avid Bioservices's Days Inventory for the three months ended in Jan. 2024 was 106.18.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Avid Bioservices's Inventory-to-Revenue for the quarter that ended in Jan. 2024 was 1.08.
The historical data trend for Avid Bioservices's Inventory Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avid Bioservices Annual Data | |||||||||||||||||||||
Trend | Apr14 | Apr15 | Apr16 | Apr17 | Apr18 | Apr19 | Apr20 | Apr21 | Apr22 | Apr23 | |||||||||||
Inventory Turnover | Get a 7-Day Free Trial | 4.09 | 6.40 | 5.85 | 4.37 | 3.37 |
Avid Bioservices Quarterly Data | ||||||||||||||||||||
Apr19 | Jul19 | Oct19 | Jan20 | Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | |
Inventory Turnover | Get a 7-Day Free Trial | 0.67 | 0.71 | 0.79 | 0.76 | 0.86 |
Avid Bioservices's Inventory Turnover for the fiscal year that ended in Apr. 2023 is calculated as
Inventory Turnover (A: Apr. 2023 ) | |||||||
= | Cost of Goods Sold | / | Average Total Inventories | ||||
= | Cost of Goods Sold (A: Apr. 2023 ) | / ( | (Total Inventories (A: Apr. 2022 ) | + | Total Inventories (A: Apr. 2023 )) | / | count ) |
= | 117.786 | / ( | (26.062 | + | 43.908) | / | 2 ) |
= | 117.786 | / | 34.985 | ||||
= | 3.37 |
Avid Bioservices's Inventory Turnover for the quarter that ended in Jan. 2024 is calculated as
Inventory Turnover (Q: Jan. 2024 ) | |||||||
= | Cost of Goods Sold | / | Average Total Inventories | ||||
= | Cost of Goods Sold (Q: Jan. 2024 ) | / ( | (Total Inventories (Q: Oct. 2023 ) | + | Total Inventories (Q: Jan. 2024 )) | / | count ) |
= | 31.432 | / ( | (38.583 | + | 34.568) | / | 2 ) |
= | 31.432 | / | 36.5755 | ||||
= | 0.86 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avid Bioservices (NAS:CDMO) Inventory Turnover Explanation
Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Avid Bioservices's Days Inventory for the three months ended in Jan. 2024 is calculated as:
Days Inventory | = | Average Total Inventories (Q: Jan. 2024 ) | / | Cost of Goods Sold (Q: Jan. 2024 ) | * | Days in Period |
= | 36.5755 | / | 31.432 | * | 365 / 4 | |
= | 106.18 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Avid Bioservices's Inventory to Revenue for the quarter that ended in Jan. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories (Q: Jan. 2024 ) | / | Revenue (Q: Jan. 2024 ) |
= | 36.5755 | / | 33.815 | |
= | 1.08 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.
Thank you for viewing the detailed overview of Avid Bioservices's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Matthew R. Kwietniak | officer: Chief Commercial Officer | 14191 MYFORD ROAD, TUSTIN CA 92780 |
Richard A. Richieri | officer: Chief Operations Officer | 14191 MYFORD ROAD, TUSTIN CA 92780 |
Daniel Ryan Hart | officer: Chief Financial Officer | 2642 MICHELLE DR., SUITE 200, TUSTIN CA 62780 |
Mark R Ziebell | officer: V.P., General Counsel | 14282 FRANKLIN AVENUE, TUSTIN CA 92780 |
Richard B Hancock | director | 14282 FRANKLIN AVE., TUSTIN CA 92780 |
Joseph Carleone | director | 3883 HOWARD HUGHES PKWY, SUITE 700, LAS VEGAS NV 89169 |
Nicholas Stewart Green | director, officer: President & CEO | 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
Gregory Sargen | director | |
Esther M. Alegria | director | 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
Mark R Bamforth | director | 500 KENDALL ST., CAMBRIDGE MA 02142 |
Jeanne Thoma | director | C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE MN 56623 |
Patrick D Walsh | director | 14282 FRANKLIN AVE., TUSTIN CA 92780 |
Catherine J Mackey | director | 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121 |
Joel Mccomb | director | 9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121 |
Stephen Michael Hedberg | officer: Principal Fin. & Acct. Officer | 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 06-14-2022
By Value_Insider Value_Insider • 11-29-2022
By GuruFocus Research • 09-23-2023
By PRNewswire PRNewswire • 06-16-2022
By GuruFocusNews GuruFocusNews • 06-13-2022
By Marketwired • 09-07-2023
By Value_Insider Value_Insider • 11-16-2022
By Value_Insider Value_Insider • 11-02-2022
By GuruFocusNews GuruFocusNews • 07-04-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.